Join a Clinical Study Looking To Find a Safer Radiation Treatment Dosage
The standard treatment for recurrent prostate cancer is radiation to the prostate bed over 6-7 weeks after removing the prostate gland. Dr. Deborah Citrin at the National Cancer Institute is conducting a study to see if a shortened or compressed radiation treatment schedule of 2, 3, or 4 weeks can be as effective as standard treatments.
Participation Criteria:
- Must have had prostatectomy for prostate cancer
- Recurrence of prostate cancer after prostatectomy (rising PSA after prostatectomy)
- Not currently on any other anti-cancer treatments
- No spread of prostate cancer outside of the pelvis
- Able to travel to the NIH Clinical Center for treatment and follow-up visits
Study Design:
- A medical history, physical exam, and blood tests
- MRI and other full-body scan
- Daily radiation treatments lasting up to 4 weeks
- Total of 9 follow-up visits for the next 2 years, beginning 4-5 weeks after initial radiation treatment
All study-related tests are provided at no cost, and travel reimbursement may be provided.
The study is located at NIH Clinical Center, America's Research Hospital is located in Bethesda, MD at Metro red line (Medical Center stop).
For more information:
NIH Clinical Center Office of Patient Recruitment
800-411-1222
TTY users dial 7-1-1
Email: ccopr@nih.gov
Or go online:
http://go.usa.gov/xtHdD
Refer to study # 18-C-0028
Department of Health and Human Services
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)